An observational study in Apnea, Obstructive Sleep and Obesity, sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Active, not recruiting at 1 site in Canada. Open to female participants aged 16 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-06.
Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 133 studies in Sleep Apnea, Obstructive with a site in Canada — 22 open to participants now, 31 under way, 4 of them phase 3. Sleep Apnea, Obstructive · Canada.
Among the 133 studies in Sleep Apnea, Obstructive with a site in Canada, this one is the 21st largest by planned enrollment of the 31 observational ones that give a count, is one of 10 that started in 2019, is one of 31 observational ones, reaches primary completion later than 11 of the 30 other live ones, and was the 92nd registered.
2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.
Browse Sleep Apnea, Obstructive studies →22 of the 133 studies in Sleep Apnea, Obstructive with a site in Canada are open now. Recruiting first, the newest first:
The Hospital for Sick Children · Sites in Canada
Ages 2–18
Eli Lilly and Company · Sites in Canada, United States, Australia and 8 more countries
Ages 18+
University of British Columbia · Sites in Canada
Ages 19+ · Healthy volunteers
University of Alberta · Sites in Canada
Ages 18+
Lena Xiao · Sites in Canada
Ages 6–18
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.
This study: 16 Years to 50 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
133 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 3 · Phase 3 19 · Phase 4 7
First in 2003; this study’s year is marked. 10 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 52 is below the median of 105 across 668 observational studies indexed under Sleep Apnea, Obstructive.
Median enrollment 60 across the 102 interventional studies, 100 across the 31 observational. Of the 86 that completed or were terminated, 10 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
27 of 133 have an industry lead sponsor. The 10 most frequent:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital is the lead sponsor of 138 studies on the registry; 17 are open to participants now.
Samuel Lunenfeld Research Institute, Mount Sinai Hospital has 1 study filed under Sleep Apnea, Obstructive — fewer than ten, so there is no comparison to draw.
9 of the studies in Sleep Apnea, Obstructive with a site in Canada that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07225686Phase 3AmgenMaridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy | 2027-08-20 |
| NCT07226765Phase 3AmgenMaridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy | 2027-08-30 |
| NCT05678088Sunnybrook Health Sciences CentreOropharyngeal Exercises to Treat Obstructive Sleep Apnea | 2026-12 |
| NCT04187612Samuel Lunenfeld Research Institute, Mount Sinai HospitalAssociation of Body Fluid Distribution With Obstructive Sleep Apnea in Pregnant Women With Body Mass Index ≥ 40 kg/m2 | 2026-12 |
| NCT07301567University of British ColumbiaPilot Study of Negative Pressure Neck Therapy (NPNT) | 2026-12 |
Add all 9 to your calendar (.ics) → With an account.
Among the 133 studies in Sleep Apnea, Obstructive with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Obstructive Sleep apnea (OSA) is a common and underdiagnosed condition in obese pregnant women with serious and life-threatening complications to the mother and baby. The investiators propose that a non-invasive method may be used to detect patients at risk of OSA, giving these women access to the necessary treatment to treat this condition. The method is a estimation of body water, which has been shown to be linked to OSA in the non-pregnant population. Body water is estimated by applying surface electrodes to a participant who is lying down by measuring bioimpedance through body tissues by applying a tiny current between the electrodes. The electrical stimulation is not felt by the participant and has no negative effects on mother or baby.
It is already established that the increasingly prevalent condition of obesity is linked to OSA in pregnancy. Obesity is increasingly prevalent This study will evaluate a novel method of screening for OSA in the obese pregnant population, thereby treating this condition reducing the ill effects to mother and fetus.
This will be a prospective observational cohort study. Eligible participants will be approached for consent during their third-trimester antenatal all-day clinic visit. Body water will be measured by connecting electrodes to participants hands, feet and neck whilst lying supine for approximately 15 minutes.
Data on patient demographics, BMI, medical conditions, water body composition and indicators of OSA (breathing pattern and oxygen levels during sleep) will be collected, as well as data from patients' sleep tests as ordered by their physician.
Eligible participants will be approached for consent at our high risk maternal and infant program clinic on the day of their regularly scheduled appointment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Total body water will be measured using Bioelectrical Impedance Analysis (BIA).
Device: Bioelectrical Impedance Analysis (BIA)
BIA will be used to determine total body water
Presence of sleep apnea
The diagnosis of sleep apnea will be made using apnea hypopnea index (AHI). A diagnosis of OSA is present if a person has an AHI ≥5/hour.
Time frame: 12 hours
Total body water measurement
Total body water will be measured using Bioelectrical Impedance Analysis (BIA)
Time frame: Following consent, this measurement will be done, and will take approximately 30 minutes
Mallampati score
The patient is asked to open their mouth wide and stick out their tongue. Upon observation, the view is classified/scored as Class 1-4. Class one would be least likely to have airway problems and 4 most likely.
Time frame: Done during initial exam following consent, this exam will take 1-2 minutes
Thyromental distance (cm)
The distance between the thyroid notch and the tip of the jaw with the head extended is evaluated.
Time frame: Done during initial exam following consent, this exam will take 1-2 minutes
Subluxation of mandible beyond maxilla
The patient is asked to extend their mandible beyond the top lip if possible. Scoring is yes or no.
Time frame: Done during initial exam following consent, this exam will take 1-2 minutes
Neck extension
The patient is asked to extend their neck, looking upwards and back, as far as comfortably possible. Scoring is yes if movement is possible, no if extension is not possible.
Time frame: Done during initial exam following consent, this exam will take 1-2 minutes
Height (cm)
Height measured in cm to calculate Body Mass index (BMI)
Time frame: Done during initial exam following consent, this exam will take 1-2 minutes
Weight (kg)
Weight measured in kg to calculate Body Mass index (BMI)
Time frame: Done during initial exam following consent, this exam will take 1-2 minutes
Neck size
Circumference around the neck, measured in centimeters.
Time frame: Done during initial exam following consent, this exam will take 1-2 minutes
Questionnaire related to snoring
Patients will be asked if they snore, if others can hear their snoring and if they are bothered by it. Yes or no answers.
Time frame: Done during initial exam following consent, this exam will take 1-2 minutes
Questionnaire related to sleep
Patients will be asked if they wake frequently during sleep, if they wake with a choking sensation, and whether they doze off or fall asleep while sitting/talking. Yes or no answers.
Time frame: Done during initial exam following consent, this exam will take 1-2 minutes
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2019 (actual). Primary completion is estimated for Dec 2026, 84 months after the start.
Of 258 non-industry observational studies under Sleep Apnea, Obstructive, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 63. This study's planned 84 months is above that.
Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 14 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Samuel Lunenfeld Research Institute, Mount Sinai Hospital →